Grant: Engage Plus Grants Program
Saint Mary's University
$12,425.00
Continued Evaluation of a Rapid Vertical Flow Assay Platform with Surface-Enhanced Raman Spectroscopy
FY 2017-18
Summary
Rapid diagnosis of human disease at the patient point-of-care is key to timely and effective treatment. Thisresearch project will explore the extent to which an advanced spectroscopic technique, known assurface-enhanced Raman spectroscopy (SERS) can be used to render a simple rapid vertical flow assay into amuch more powerful quantitative test. A quantitative rapid vertical flow assay, which this project seeks todemonstrate, would allow for earlier detection of human disease, and would allow for improved health caremonitoring (such as in determination of HIV viral load, etc). All of this would still be possible at the patientpoint-of-care, which would ensure rapid and effective disease treatment. Our recent Engage project is comingto an end, and we have made excellent progress on this front. Improved limit-of-detection and increasedselectivity have been illustrated, as well as guidelines for the production of stable and reproducible goldcolloids conjugated with both the capture agent and the Raman-active label. However, there is still much workto do, including pushing the limit of detection further through the exploration of other shapes / sizes ofparticles, as well as testing in biologically relevant matrices (i.e. serum). In addition, a robust data analyticsapproach is needed to advance the technology forward.
Program
Engage Plus Grants Program
Recipient
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
508399-2017
Name nom
Brosseau, Christa
Department département
Chemistry
Organization id
85
Institution établissement
Saint Mary's University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
12425
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3505
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical spectroscopy
Research subject fr
Spectroscopie analytique
Partie
1
Nb partie
1
Application title
Continued Evaluation of a Rapid Vertical Flow Assay Platform with Surface-Enhanced Raman Spectroscopy
Keyword
NSERC
Application summary
Rapid diagnosis of human disease at the patient point-of-care is key to timely and effective treatment. Thisresearch project will explore the extent to which an advanced spectroscopic technique, known assurface-enhanced Raman spectroscopy (SERS) can be used to render a simple rapid vertical flow assay into amuch more powerful quantitative test. A quantitative rapid vertical flow assay, which this project seeks todemonstrate, would allow for earlier detection of human disease, and would allow for improved health caremonitoring (such as in determination of HIV viral load, etc). All of this would still be possible at the patientpoint-of-care, which would ensure rapid and effective disease treatment. Our recent Engage project is comingto an end, and we have made excellent progress on this front. Improved limit-of-detection and increasedselectivity have been illustrated, as well as guidelines for the production of stable and reproducible goldcolloids conjugated with both the capture agent and the Raman-active label. However, there is still much workto do, including pushing the limit of detection further through the exploration of other shapes / sizes ofparticles, as well as testing in biologically relevant matrices (i.e. serum). In addition, a robust data analyticsapproach is needed to advance the technology forward.